{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:53:38Z","timestamp":1789505618336,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since the emergence of the COVID-19 pandemic, the successful distribution and application of mRNA vaccines have helped to contain the spread of SARS-CoV-2 and saved countless lives worldwide. mRNA vaccines are not only being developed and tested for infectious diseases, but also for numerous new applications, such as cancer therapy. Although the general mechanisms of mRNA vaccinations have been thoroughly studied, data regarding the local anatomical distribution after vaccination have been scarce. Here, we investigated the spatiotemporal distribution of BNT162b2 and mRNA-1273 vaccines in mice and deceased humans. We found that vaccine-related mRNA and spike protein could be detected at the vaccination site of patients and mice, with muscle-associated fibroblasts being a major source of spike protein expression. In contrast, we did not detect expression of vaccine-related spike protein in immune cells at the injection site. While mRNA-vaccine-related mRNA or spike protein could not be detected in extramuscular organs in humans in our study, it was detected in several organs in mice, even up to 7 days after initial vaccination. Together, these data enhance our understanding of mRNA vaccine kinetics and distribution patterns, providing valuable insights to guide scientists in refining future mRNA vaccine-based therapies whenever appropriate.<\/jats:p>","DOI":"10.1038\/s41598-026-47568-6","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:40:26Z","timestamp":1779180026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans"],"prefix":"10.1038","volume":"16","author":[{"given":"Fabian","family":"Heinrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6ran","family":"L\u00fccke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morsal","family":"Sabihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bernreuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Giersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Allweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Matschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja A.","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronja","family":"Mothes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Sophie","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Aepfelbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Giannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ondruschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Krasemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"47568_CR1","unstructured":"Cascella, M. et al. Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls (Treasure Island (FL), 2024)."},{"issue":"7942","key":"47568_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","volume":"613","author":"W Msemburi","year":"2023","unstructured":"Msemburi, W. et al. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature 613 (7942), 130\u2013137 (2023).","journal-title":"Nature"},{"issue":"7830","key":"47568_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","volume":"586","author":"MJ Mulligan","year":"2020","unstructured":"Mulligan, M. J. et al. Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586 (7830), 589\u2013593 (2020).","journal-title":"Nature"},{"issue":"2","key":"47568_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Kariko","year":"2005","unstructured":"Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23 (2), 165\u2013175 (2005).","journal-title":"Immunity"},{"issue":"27","key":"47568_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl. J. Med. 383 (27), 2603\u20132615 (2020).","journal-title":"N Engl. J. Med."},{"issue":"5","key":"47568_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl. J. Med. 384 (5), 403\u2013416 (2021).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"47568_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12879-022-07418-y","volume":"22","author":"P Ssentongo","year":"2022","unstructured":"Ssentongo, P. et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect. Dis. 22 (1), 439 (2022).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"47568_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell. Biol. 23 (1), 3\u201320 (2022).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"47568_CR9","doi-asserted-by":"crossref","unstructured":"Jacob-Dolan, C. et al. Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques. Sci. Transl. Med. 17(806), eadu7646 (2025).","DOI":"10.1126\/scitranslmed.adu7646"},{"key":"47568_CR10","doi-asserted-by":"crossref","unstructured":"Parks, K. R. et al. Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial. Sci. Transl. Med. 17(809), eady6831 (2025).","DOI":"10.1126\/scitranslmed.ady6831"},{"key":"47568_CR11","doi-asserted-by":"crossref","unstructured":"Ramezani-Rad, P. et al. Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models. Sci. Transl. Med. 17(809), eadw0721 (2025).","DOI":"10.1126\/scitranslmed.adw0721"},{"key":"47568_CR12","unstructured":"Willis, J. R. et al. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science 389(6759), eadr8382 (2025)."},{"issue":"7","key":"47568_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","volume":"21","author":"EJ Sayour","year":"2024","unstructured":"Sayour, E. J., Boczkowski, D., Mitchell, D. A. & Nair, S. K. Cancer mRNA vaccines: clinical advances and future opportunities. Nat. Rev. Clin. Oncol. 21 (7), 489\u2013500 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"14","key":"47568_CR14","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185 (14), 2434\u201351e17 (2022).","journal-title":"Cell"},{"issue":"3","key":"47568_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","volume":"7","author":"GA Roth","year":"2022","unstructured":"Roth, G. A. et al. Designing spatial and temporal control of vaccine responses. Nat. Rev. Mater. 7 (3), 174\u2013195 (2022).","journal-title":"Nat. Rev. Mater."},{"issue":"5","key":"47568_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","volume":"3","author":"KE Lindsay","year":"2019","unstructured":"Lindsay, K. E. et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging. Nat. Biomed. Eng. 3 (5), 371\u2013380 (2019).","journal-title":"Nat. Biomed. Eng."},{"issue":"7607","key":"47568_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534 (7607), 396\u2013401 (2016).","journal-title":"Nature"},{"issue":"3","key":"47568_CR18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","volume":"33","author":"M Buckley","year":"2025","unstructured":"Buckley, M. et al. Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. Mol. Ther. 33 (3), 1105\u20131117 (2025).","journal-title":"Mol. Ther."},{"issue":"1","key":"47568_CR19","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1038\/s41467-024-51411-9","volume":"15","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-beta at the injection site. Nat. Commun. 15 (1), 7226 (2024).","journal-title":"Nat. Commun."},{"key":"47568_CR20","doi-asserted-by":"publisher","unstructured":"Heinrich, F. et al. SARS-CoV-2 blood RNA load predicts outcome in critically ill COVID-19 patients. Open Forum Infect. Diseases 8(11), ofab509. https:\/\/doi.org\/10.1093\/ofid\/ofab509 (2021).","DOI":"10.1093\/ofid\/ofab509"},{"issue":"7830","key":"47568_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586 (7830), 567\u2013571 (2020).","journal-title":"Nature"},{"issue":"7853","key":"47568_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","volume":"592","author":"AB Vogel","year":"2021","unstructured":"Vogel, A. B. et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592 (7853), 283\u2013289 (2021).","journal-title":"Nature"},{"issue":"12","key":"47568_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jmoldx.2020.09.004","volume":"22","author":"W Zhen","year":"2020","unstructured":"Zhen, W. & Berry, G. J. Development of a New Multiplex Real-Time RT-PCR Assay for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Detection. J. Mol. Diagn. 22 (12), 1367\u20131372 (2020).","journal-title":"J. Mol. Diagn."},{"issue":"6561","key":"47568_CR24","doi-asserted-by":"publisher","first-page":"eabj0299","DOI":"10.1126\/science.abj0299","volume":"373","author":"KS Corbett","year":"2021","unstructured":"Corbett, K. S. et al. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. Science 373 (6561), eabj0299 (2021).","journal-title":"Science"},{"issue":"4","key":"47568_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23 (4), 543\u2013555 (2022).","journal-title":"Nat. Immunol."},{"issue":"11","key":"47568_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke, J. et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19 (11), 919\u2013929 (2020).","journal-title":"Lancet Neurol."},{"key":"47568_CR27","doi-asserted-by":"crossref","unstructured":"Krasemann, S. et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47(3) 566\u2013581 (2017).","DOI":"10.1016\/j.immuni.2017.08.008"},{"key":"47568_CR28","unstructured":"European Medicines Agency. Assessment report EMA\/707383\/2020. (2021). https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/comirnaty-epar-public-assessment-report_en.pdf (accessed 28.10.2021)."},{"issue":"12","key":"47568_CR29","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","volume":"25","author":"F Liang","year":"2017","unstructured":"Liang, F. et al. Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques. Mol. Ther. 25 (12), 2635\u20132647 (2017).","journal-title":"Mol. Ther."},{"issue":"5","key":"47568_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2025.03.004","volume":"46","author":"B Brook","year":"2025","unstructured":"Brook, B., Goetz, M., Duval, V., Micol, R. & Dowling, D. J. mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantation. Trends Immunol. 46 (5), 357\u2013360 (2025).","journal-title":"Trends Immunol."},{"key":"47568_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","volume":"217","author":"N Pardi","year":"2015","unstructured":"Pardi, N. et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control Release. 217, 345\u2013351 (2015).","journal-title":"J. Control Release"},{"issue":"1","key":"47568_CR32","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.omtn.2023.102083","volume":"35","author":"KJ Hassett","year":"2024","unstructured":"Hassett, K. J. et al. mRNA vaccine trafficking and resulting protein expression after intramuscular administration. Mol. Ther. Nucleic Acids. 35 (1), 102083 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"39","key":"47568_CR33","doi-asserted-by":"publisher","first-page":"27077","DOI":"10.1021\/acsnano.4c11652","volume":"18","author":"SJ Kent","year":"2024","unstructured":"Kent, S. J. et al. Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 18 (39), 27077\u201327089 (2024).","journal-title":"ACS Nano"},{"issue":"6","key":"47568_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K Roltgen","year":"2022","unstructured":"Roltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185 (6), 1025\u201340e14 (2022).","journal-title":"Cell"},{"key":"47568_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","volume":"333","author":"R Verbeke","year":"2021","unstructured":"Verbeke, R., Lentacker, I., De Smedt, S. C. & Dewitte, H. The dawn of mRNA vaccines: The COVID-19 case. J. Control Release. 333, 511\u2013520 (2021).","journal-title":"J. Control Release"},{"issue":"7872","key":"47568_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","volume":"596","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam, P. S. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596 (7872), 410\u2013416 (2021).","journal-title":"Nature"},{"key":"47568_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","volume":"2","author":"J Lutz","year":"2017","unstructured":"Lutz, J. et al. Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. NPJ Vaccines. 2, 29 (2017).","journal-title":"NPJ Vaccines"},{"issue":"12","key":"47568_CR38","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","volume":"25","author":"F Liang","year":"2017","unstructured":"Liang, F. et al. Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques. Mol. Ther. 25 (12), 2635\u20132647 (2017).","journal-title":"Mol. Ther."},{"issue":"11","key":"47568_CR39","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke, R., Hogan, M. J., Lore, K. & Pardi, N. Innate immune mechanisms of mRNA vaccines. Immunity 55 (11), 1993\u20132005 (2022).","journal-title":"Immunity"},{"key":"47568_CR40","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jconrel.2020.11.033","volume":"330","author":"AK Blakney","year":"2021","unstructured":"Blakney, A. K. et al. Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants. J. Control Release. 330, 1250\u20131261 (2021).","journal-title":"J. Control Release"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47568-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47568-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47568-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:40:30Z","timestamp":1779180030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47568-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47568"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47568-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15479"}}